广发创新医疗两年持有混合C(010732)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
127,042,836.04 |
-37,386,315.21 |
-56,311,338.78 |
-94,024,385.96 |
| 利息合计 |
111,013.30 |
179,646.42 |
79,268.93 |
204,627.42 |
| 其中：存款利息收入 |
55,889.65 |
179,646.42 |
79,268.93 |
204,627.42 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
55,123.65 |
- |
- |
- |
| 投资收益合计 |
22,996,077.98 |
-48,295,487.30 |
-45,067,997.20 |
-163,076,008.51 |
| 其中：股票投资收益 |
21,489,808.38 |
-51,517,982.07 |
-47,335,065.02 |
-167,132,571.32 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
-1,975.55 |
31,020.63 |
31,020.63 |
2,814.04 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,508,245.15 |
3,191,474.14 |
2,236,047.19 |
4,053,748.77 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
103,935,744.76 |
10,729,525.67 |
-11,322,610.51 |
68,846,995.13 |
| 其他收入 |
- |
- |
- |
- |
| 费用 |
2,747,624.26 |
5,501,683.80 |
2,859,153.54 |
8,951,186.90 |
| 管理人报酬 |
2,151,875.60 |
4,297,303.88 |
2,235,875.86 |
7,098,344.38 |
| 基金托管费 |
358,645.87 |
716,217.26 |
372,645.97 |
1,183,057.41 |
| 销售服务费 |
145,246.57 |
304,822.49 |
159,253.35 |
470,448.32 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
91,856.22 |
183,340.05 |
91,378.24 |
199,336.79 |
| 利润总额 |
124,295,211.78 |
-42,887,999.01 |
-59,170,492.32 |
-102,975,572.86 |
微信公众号
证券之星APP
基本资料
